Study finds most children with MS have slow-growing brain lesions
Most children with multiple sclerosis (MS) have chronic active lesions that slowly get bigger over time, and their frequency…
Articles by Lila Levinson, PhD
Zenas completes enrollment for Phase 2 trial of obexelimab for MS
Enrollment is complete for a Phase 2 trial testing Zenas Biopharma’s obexelimab in people with relapsing forms of…
Insurance plans that limit MS drugs may lead to worse patient outcomes
People with multiple sclerosis (MS) may be significantly more likely to have relapses if their Medicare insurance covers fewer…
Dementia risk significantly higher for people with MS: Meta-analysis
People with multiple sclerosis (MS) have a significantly greater risk of developing dementia compared with the general population, according…
Task-oriented training may help MS balance issues, study finds
Task-oriented training may help balance issues for people with multiple sclerosis (MS), particularly when combined with conventional physiotherapy, according…
MS prevalence in New Zealand rose by one-third from 2006-2022: Study
Among people in New Zealand, the proportion of individuals with multiple sclerosis (MS) — the disease’s prevalence, or how…
Study: Chronic lower body pain in MS alters gait patterns
People with multiple sclerosis (MS) who have chronic lower body pain show distinct changes in how they walk, including…
Partners to commercialize Kesimpta biosimilar drug for MS in Europe
Alvotech, a developer of biosimilar medicines, is expanding its partnership with Advanz Pharma to commercialize three new products…
Pediatric-onset MS children have higher healthcare needs from birth
Children with pediatric-onset multiple sclerosis (MS) tend to use more healthcare resources than their peers, starting from birth and…
Varying impact on risk of stroke found for DMT use in MS in study
As a whole, disease-modifying therapies (DMTs) for multiple sclerosis (MS) tend to reduce the risk of stroke among…
Cognitive symptoms, mood disorders vary with MS subtype
Cognitive symptoms, mood disorders, and fatigue manifest differently in relapsing-remitting and progressive forms of multiple sclerosis (MS), a study…
50+ events planned May 25 for nationwide MS Walks in Canada
MS Canada is inviting people across the country to support the multiple sclerosis (MS) community and help raise…
Demographic, disease factors linked to MS progression risk
Factors including being male, smoking, and having more frequent relapses are linked to significantly increased risk of disease progression in…
Quantum inks agreement to prep filing for Lucid-MS Phase 2 trial
Quantum Biopharma has signed an agreement with a global pharmaceutical contract research organization to continue advancing Lucid-21-302, its experimental…
At-home neural stimulation lowers cannabis withdrawal in MS women
Supervised, noninvasive at-home neural stimulation helped women with multiple sclerosis (MS) and cannabis use disorder (CUD) decrease their cannabis…
Having close friend linked to better well-being in women with MS
Women with multiple sclerosis (MS) who have a close friend to confide in experience better physical and mental health…
Increasing frailty in RRMS patients linked to higher IL-6 levels: Study
The signaling molecule interleukin-6 (IL-6), which is involved in inflammation, is associated with increasing frailty in people with multiple…
High-efficacy RRMS therapies may help maintain capacity to work
The use of high-efficacy disease modifying therapies (DMTs) among relapsing-remitting multiple sclerosis (RRMS) patients may aid their capacity to…
United Healthcare approves reimbursement for MS PoNS device
United Healthcare will reimburse the cost of the PoNS device, which uses electrical stimulation to improve walking, for…
Worsening disability tied to loss of bone mineral density in MS
Worsening disability in people with multiple sclerosis (MS) is associated with a significantly greater likelihood of losing bone mineral…
Wim Hof method shows significant benefits for MS patients: Study
A 12-week program based on the Wim Hof method (WHM) — which combines cold exposure, breathing exercises, and mindfulness —…
National MS Society gives more than $18M for research, training
The National Multiple Sclerosis Society is investing more than $18 million in new grants and fellowships to support…
Activities, events planned for MS Awareness Month in Canada
May marks Multiple Sclerosis Awareness Month in Canada, and people across the country can take part in advocacy and fundraising…
Octave’s MS disease activity test now available across US
Octave Bioscience’s Multiple Sclerosis Disease Activity (MSDA) test, which uses data from blood biomarkers to assess multiple sclerosis (MS)…
Nondrug therapy costs high for MS patients in Austria, study finds
People with multiple sclerosis (MS) in Austria spend an average of €136 (about $149) per month on nondrug therapies…
Study: Younger age of disease onset for Asian Americans with MS
People of Asian descent tend to be younger than white people when they first exhibit symptoms of multiple sclerosis…
Fibroblast therapy helps restore myelin in 2 mouse models of MS
Fibrobiologics’ investigational cell therapy CYMS101Â can significantly increase myelin production and promote myelin repair in a mouse model of…
Longer rituximab treatment intervals don’t affect safety, efficacy
People with multiple sclerosis (MS) may receive less frequent infusions of rituximab without increasing their chances of relapse or…